Speeding the Weaning up: Aggressive Screening Criteria and Higher Minimal Ventilatory Settings.
SPEED-UP
Customizing Spontaneous Breathing Trial After Aggressive Readiness Criteria Hastens Weaning in Low and Intermediate Risk Patients With Prevention: A Randomized Trial (SPEED-UP Trial).
1 other identifier
interventional
940
1 country
1
Brief Summary
Hypothesis:
- 1.In patients with less than 4 high risk factors for reintubation excluding body mass index \>30 and hypercapnia during the spontaneous breathing trial (SBT) (low and intermediate risk for extubation failure), who receive preventive therapy with high flow nasal cannula (HFNC), the use of SBT with "HIGH minimal ventilator settings" (PS 8 + PEEP 5 cm H2O Vs PS 5 + PEEP 0 cm H2O), increase the proportion of patients with simple weaning (extubation after the first SBT).
- 2.In patients with low and intermediate risk for extubation failure, who receive preventive therapy with HFNC, the use of Walsh screening criteria reduces the mechanical ventilation time compared with the use of Boles criteria.
- 3.Screening with PaO2/FiO2 \> 180 and PEEP ≤ 10cm H2O; SBT with "HIGH minimal ventilator settings" (PS 8 + PEEP 5 cm H2O).
- 4.Screening with PaO2/FiO2 \> 180 and PEEP ≤ 10 cm H2O; SBT with "LOW minimal ventilator settings" (PS 5 + PEEP 0 cm H2O).
- 5.Screening with PaO2/FiO2 ≥ 150 and PEEP ≤ 8 cm H2O; SBT with "HIGH minimal ventilator settings" (PS 8 + PEEP 5 cm H2O).
- 6.Screening with PaO2/FiO2 ≥ 150 and PEEP ≤ 8 cm H2O; SBT with "LOW minimal ventilator settings" (PS 5 + PEEP 0 cm H2O).
- 7.\- Percentage of first spontaneous breathing trial tolerated.
- 8.\- Time on mechanical ventilation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 11, 2021
CompletedFirst Posted
Study publicly available on registry
February 17, 2021
CompletedStudy Start
First participant enrolled
March 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2023
CompletedApril 6, 2023
April 1, 2023
2.1 years
February 11, 2021
April 4, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Percentage of first spontaneous breathing trial tolerated
1 month after intubation
Time on mechanical ventilation
1 month after intubation
Secondary Outcomes (5)
Reintubation rate
7 days after extubation
Post-extubation respiratory failure rate
7 days after extubation
ICU and Hospital length of stay
3 months after ICU and Hospital admission
ICU and Hospital mortality rate
3 months after ICU and Hospital admission
Sepsis and multiorgan failure rate
3 months after ICU and Hospital admission
Study Arms (4)
Aggressive screening criteria + high minimal ventilatory settings
EXPERIMENTALAggressive screening criteria + low minimal ventilatory settings
EXPERIMENTALConservative screening criteria + high minimal ventilatory settings
EXPERIMENTALConservative screening criteria + low minimal ventilatory settings
ACTIVE COMPARATORInterventions
Aggressive screening criteria: Walsh Conservative screening criteria: Boles High minimal ventilatory settings: pressure Support 8 + positive end-expiratory pressure 5 Low minimal ventilatory settings: pressure support 5
Eligibility Criteria
You may qualify if:
- Patients on mechanical ventilation for more than 24 hours with \>= positive end-expiratory pressure 10.
- Patients with up to three high risk factors for extubation failure excluding hypercapnia during the spontaneous breathing trial and obese patients (BMI \>30).
- Patients fulfilling weaning criteria expected to have a spontaneous breathing trial in the following 24 hours.
- Patients expected to be prevented with high-flow oxygen therapy after extubation.
You may not qualify if:
- \<18 years old.
- Pregnant women.
- Tracheostomized patients.
- Accidental or self-extubated patients.
- Obese (BMI \>30) or hypercapnic patients during the spontaneous breathing trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Virgen de la Salud
Toledo, Castille-La Mancha, 45007, Spain
Related Publications (1)
Hernandez Martinez G, Rodriguez P, Soto J, Caritg O, Castellvi-Font A, Mariblanca B, Garcia AM, Colinas L, Anon JM, Parrilla-Gomez FJ, Silva-Obregon JA, Masclans JR, Propin A, Cuadra A, Dalorzo MG, Rialp G, Suarez-Sipmann F, Roca O. Effect of aggressive vs conservative screening and confirmatory test on time to extubation among patients at low or intermediate risk: a randomized clinical trial. Intensive Care Med. 2024 Feb;50(2):258-267. doi: 10.1007/s00134-024-07330-w. Epub 2024 Feb 14.
PMID: 38353714DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Gonzalo Hernandez
University Hospital Virgen de la Salud
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
February 11, 2021
First Posted
February 17, 2021
Study Start
March 1, 2021
Primary Completion
March 31, 2023
Study Completion
March 31, 2023
Last Updated
April 6, 2023
Record last verified: 2023-04